Edoxaban for treatment of venous thromboembolism in patients with cancer Rationale and design of the Hokusai VTE-cancer study

Nick van Es*, Marcello Di Nisio, Suzanne M. Bleker, Annelise Segers, Michele F. Mercuri, Lee Schwocho, Ajay Kakkar, Jeffrey I. Weitz, Jan Beyer-Westendorf, Zoltan Boda, Marc Carrier, Jaromir Chlumsky, Herve Decousus, David Garcia, Harry Gibbs, Pieter W. Kamphuisen, Manuel Monreal, Paul Ockelford, Ingrid Pabinger, Peter VerhammeMichael A. Grosso, Harry R. Bueller, Gary E. Raskob

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

81 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Edoxaban for treatment of venous thromboembolism in patients with cancer Rationale and design of the Hokusai VTE-cancer study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases